Glaukos to Showcase Innovative Ophthalmic Technologies at ASCRS 2026

Glaukos announced that its latest technologies will be featured across multiple scientific sessions at the American Society of Cataract and Refractive Surgery (ASCRS) annual meeting, taking place April 10-13, 2026, in Washington, D.C.

The company will exhibit its portfolio of products and pipeline innovations at booth #407.

In addition to its exhibition presence, Glaukos will sponsor an educational symposium in partnership with ASCRS and EyeWorld titled, “Introducing Epioxa, the first and only FDA-approved, epithelium-on, oxygen-enriched corneal cross-linking treatment.” The session is scheduled for Friday, April 10, from 12:00–1:00 p.m. ET in Room 102 AB at the Walter E. Washington Convention Center.

The symposium will be moderated by Brandon D. Ayres, MD, and feature a panel of experts including Kenneth A. Beckman, MD; Maanasa Indaram, MD; and Matt Jensen, MBA. The program will highlight clinical insights and advancements in corneal cross-linking therapies, particularly focusing on the newly approved Epioxa treatment.

Scientific Presentations Highlight Pipeline and Clinical Progress

Glaukos-supported research will also be presented in several key sessions throughout the meeting, emphasizing advancements in glaucoma and corneal health:

Saturday, April 11

• 1:40–1:45 p.m. — Arkadiy Yadgarov, MD: 12-Month Outcomes of Standalone Third-Generation Trabecular Micro-Bypass Stents in Eyes with Open-Angle Glaucoma
• 2:01–2:06 p.m. — Michael B. Raizman, MD: Design Review and Clinical Plan for Novel Keratoconus Screening Device

Sunday, April 12

• 1:40–1:45 p.m. — Jasmin Kaur / Savak Teymoorian, MD: 12-Month Single-Center Outcomes of Travoprost Intracameral Implant in Eyes with Open-Angle Glaucoma or Ocular Hypertension
• 3:35–3:40 p.m. — Lisa K. Feulner, MD: Real-World Outcomes of Combining Trabecular Micro-Bypass Stents with Intracameral Travoprost Implant or Cataract Surgery

On-Demand Posters Showcase Additional Clinical Data

A series of on-demand poster presentations will further detail clinical outcomes and safety data related to Glaukos technologies. Topics include the durability of epithelium-on corneal cross-linking, combination therapies involving trabecular micro-bypass stents and travoprost implants, and long-term outcomes in glaucoma patients undergoing minimally invasive procedures.

Contributing authors include Kenneth A. Beckman, MD; John P. Berdahl, MD; Christine N. Funke, MD; Steven R. Sarkisian Jr., MD; and Zachary D. Vest, MD.

Abstracts and additional meeting information are available through the official ASCRS annual meeting website.